Seer, Inc. (California) (SEER)
2.25
+0.05
(+2.27%)
USD |
NASDAQ |
Oct 02, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Seer Cash from Operations (TTM) : -43.38M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.38M |
| March 31, 2026 | -48.47M |
| December 31, 2025 | -44.45M |
| September 30, 2025 | -45.10M |
| June 30, 2025 | -51.66M |
| March 31, 2025 | -47.07M |
| December 31, 2024 | -46.11M |
| September 30, 2024 | -44.84M |
| June 30, 2024 | -45.13M |
| March 31, 2024 | -50.19M |
| Date | Value |
|---|---|
| December 31, 2023 | -59.06M |
| September 30, 2023 | -63.13M |
| June 30, 2023 | -62.09M |
| March 31, 2023 | -60.96M |
| December 31, 2022 | -60.78M |
| September 30, 2022 | -58.89M |
| June 30, 2022 | -54.28M |
| March 31, 2022 | -50.63M |
| December 31, 2021 | -46.35M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Champions Oncology, Inc. | -5.564M |
| Medpace Holdings, Inc. | 752.66M |
| Avantor, Inc. | 597.00M |
| Personalis, Inc. | -92.30M |
| Adaptive Biotechnologies Corp. | -21.01M |